Drugs / TL011
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01205737 | Sep 2010 → Jul 2013 | diffuse large B-cell lymphoma | Teva Branded Pharmaceutical Products R&D, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01123070 | Feb 2010 → Apr 2012 | rheumatoid arthritis | Teva Pharmaceutical Industries, Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TL011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01205737 ↗ |